Yasuda, Hiromi <br/><br/>
Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer.  [electronic resource] 

 -  Oncology reports  Oct 2009 
 - 709-17 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1021-335X 
<br/><br/><label>Standard No.: </label>10.3892/or_00000491  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AC133 Antigen<br/>Adult<br/>Aged<br/>Antigens, CD--biosynthesis<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor--analysis<br/>Combined Modality Therapy<br/>Disease-Free Survival<br/>ErbB Receptors--biosynthesis<br/>Female<br/>Gene Expression<br/>Gene Expression Profiling<br/>Glycoproteins--biosynthesis<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Male<br/>Microdissection<br/>Middle Aged<br/>Neoadjuvant Therapy--methods<br/>Neoplasm Recurrence, Local--genetics<br/>Neoplasm Staging<br/>Neovascularization, Pathologic--genetics<br/>Peptides--genetics<br/>RNA, Messenger--analysis<br/>Radiotherapy<br/>Rectal Neoplasms--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Vascular Endothelial Growth Factor A--biosynthesis